Hi Thunder, I can't see that post you're referring to but yes......

Hi Thunder, I can't see that post you're referring to but yes... some people are bitter and have their eyes firmly focused on the rear view mirror.

BTA in my eyes have a very bright future, they have cash, cashflow, and a very prospective clinical program in late stage trial. All for under $100m!

The distraction of the GSK affair is behind them and we are now seeing a very active push by GSK yield results. The UK order ahead of analyst predictions and a massive lift in seasonal Japanese sales.

My shares are firmly locked in the bottom drawer. $5 target in 3 years for me.